StockData
ResMed Inc logo

ResMed Inc

RMDNYSESurgical & Medical Instruments & ApparatusFiscal year ends June 30Also trades as RSMDF
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 21/3011% below fair value
$242.61+4.76 (+2.00%)

Close on Nov 18, 2026Market cap $34.12BP/E 22.1Yield 0.99%

ResMed ClinicalTrials.gov Newly Started Studies by Quarter

ClinicalTrials.gov Newly Started Studies — ResMed

Periods

ResMed ClinicalTrials.gov Newly Started Studies: 2 in Q1 FY27, unchanged from a year earlier.

Latest, Q1 FY27
2
Period ended Sep 30, 2026 (CQ3 2026)
Change on a year earlier
0.0%
2 in Q1 FY26
History
33 quarters
Since Q3 FY16
Sources
1
NIH ClinicalTrials.gov Registry — ResMed

Where the Q1 FY27 figure comes from

Source: NIH ClinicalTrials.gov Registry — ResMed ↗

Reported in NIH ClinicalTrials.gov API v2 (166 Lead-Sponsor ResMed Studies).

quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedClinicalTrials.gov Newly Started Studies — ResMedYear on yearSource
Q1 FY27CQ3 2026Sep 30, 202620.0%NIH ClinicalTrials.gov Registry — ResMed ↗
Q4 FY26CQ2 2026Jun 30, 20263+200.0%NIH ClinicalTrials.gov Registry — ResMed ↗
Q3 FY26CQ1 2026Mar 31, 20262+100.0%NIH ClinicalTrials.gov Registry — ResMed ↗
Q1 FY26CQ3 2025Sep 30, 20252–NIH ClinicalTrials.gov Registry — ResMed ↗
Q4 FY25CQ2 2025Jun 30, 20251-50.0%NIH ClinicalTrials.gov Registry — ResMed ↗
Q3 FY25CQ1 2025Mar 31, 20251-50.0%NIH ClinicalTrials.gov Registry — ResMed ↗
Q4 FY24CQ2 2024Jun 30, 20242+100.0%NIH ClinicalTrials.gov Registry — ResMed ↗
Q3 FY24CQ1 2024Mar 31, 20242+100.0%NIH ClinicalTrials.gov Registry — ResMed ↗
Q2 FY24CQ4 2023Dec 31, 20231–NIH ClinicalTrials.gov Registry — ResMed ↗
Q1 FY24CQ3 2023Sep 30, 20231-50.0%NIH ClinicalTrials.gov Registry — ResMed ↗
Q4 FY23CQ2 2023Jun 30, 20231-66.7%NIH ClinicalTrials.gov Registry — ResMed ↗
Q3 FY23CQ1 2023Mar 31, 20231–NIH ClinicalTrials.gov Registry — ResMed ↗
Q1 FY23CQ3 2022Sep 30, 202220.0%NIH ClinicalTrials.gov Registry — ResMed ↗
Q4 FY22CQ2 2022Jun 30, 20223+200.0%NIH ClinicalTrials.gov Registry — ResMed ↗
Q1 FY22CQ3 2021Sep 30, 20212-33.3%NIH ClinicalTrials.gov Registry — ResMed ↗
Q4 FY21CQ2 2021Jun 30, 20211-50.0%NIH ClinicalTrials.gov Registry — ResMed ↗

Breakdown

What makes up clinicalTrials.gov Newly Started Studies

Cite this data

StockData. (2026). ResMed ClinicalTrials.gov Newly Started Studies, quarterly Q3 FY16–Q1 FY27 [Data set]. Compiled from ResMed SEC filings and investor materials. https://stockdatahq.com/stocks/rmd/kpis/ext-ct-started

See every metric in the ResMed KPI table. Data updated Nov 8, 2026.

See a number that looks wrong?